Ratings by Evercore ISI (Michael DiFiore)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2026 | Altimmune | ALT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2026 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2026 | vTv Therapeutics | VTVT | New Coverage | Outperform (N/A) |
35.10 (35.33) |
0.66% | Details | |
| 1/27/2026 | Altimmune | ALT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2025 | 89bio Inc. | ETNB | New Coverage | Outperform (N/A) |
9.43 (14.84) |
57.37% | Details | |
| 8/25/2025 | Madrigal Pharmaceuticals | MDGL | New Coverage | Outperform (N/A) |
414.68 (513.43) |
23.81% | Details | |
| 8/25/2025 | Altimmune | ALT | New Coverage | Outperform (N/A) |
3.54 (2.91) |
-17.8% | Details | |
| 8/25/2025 | Akero Therapeutics | AKRO | New Coverage | Outperform (N/A) |
49.23 (54.74) |
11.19% | Details | |
| 8/15/2025 | Sykes Enterprises | SYKE | New Coverage | Outperform (N/A) |
54.00 (54.00) |
0% | Details | |
| 6/23/2025 | Fractyl Health Inc | GUTS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2025 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2022 | Cincor Pharma Inc | CINC | New Coverage | Outperform (N/A) |
19.07 (29.06) |
52.39% | Details |
